Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:1-Methylguanine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000923 AN001513 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease The Broad Institute Abundance
ST001000 AN001878 Gut microbiome structure and metabolic activity in inflammatory bowel disease Feces Human The Broad Institute Abundance
ST002470 AN004029 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard Abundance
ST002471 AN004033 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard Abundance
ST002247 AN003670 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard Abundances
ST002761 AN004487 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin Area
ST002761 AN004489 Metabolic responses of normal rat kidneys to a high salt intake (Urine) Urine Rat Medical College of Wisconsin Area
ST002755 AN004472 Metabolomics Profiling of the Antiproliferative, Anti-migratory and Anti-invasive Potential of Amlodipine in Lung Cancer Cells Lung Human Cancer Sharjah Institute for Medical Research AU
ST002903 AN004762 Identification and targeting of microbial putrescine acetylation in bloodstream infections Blood Human Septic shock Broad Institute of MIT and Harvard integrated peak area
ST002797 AN004550 Fetal metabolic adaptations to cardiovascular stress in twin-twin transfusion syndrome Amniotic fluid Human Twin-twin transfusion syndrome University of Texas Health Science Center at Houston intensity
ST002149 AN003519 In vivo commensal control of Clostridioides difficile virulence Cecum Mouse Brigham and Women’s Hospital Intensity
ST002775 AN004518 Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Normalized Concentrations
ST002444 AN003982 Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami normalized peak areas
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center osmolality normalized scaled imputed
ST002536 AN004171 Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma Thyroid Human Cancer Broad Institute of MIT and Harvard peak area
ST002654 AN004326 MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted HILIC-Positive Kidney Rat Broad Institute peak area
ST002674 AN004346 MoTrPAC: Endurance exercise training study in young adult rats, Rat Small Intestine Powder - Untargeted HILIC-Positive Small intestine Rat Broad Institute peak area
ST002399 AN003906 Metabolomics of Adipocyte-Conditioned Media Compared to Stromal Cell- and Un-conditioned Media Cultured cells Mouse Obesity Emory University Peak area
ST002776 AN004519 Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Peak Area
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000667 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000669 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST002090 AN003414 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) Feces Mouse Irritable bowel syndrome Mayo Clinic raw intensity
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000080 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000083 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000930 AN001524 Define alterations in the gut metabolome of mice infected with C. difficile Intestine Mouse North Carolina State University scaled intensity
ST002246 AN003666 Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study Feces Human Broad Institute of MIT and Harvard Unitless Abundances
ST001519 AN002525 Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) Feces Human Broad Institute of MIT and Harvard unitless peak areas
ST001521 AN002533 Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) Blood Human Broad Institute of MIT and Harvard unitless peak areas
  logo